As a few of the many diagnostic companies that are pioneers of medical innovation in the modern age, these pharmaceutical businesses are rolling out new, precise drug therapies at an unprecedented rate to combat specific medical issues by introducing diagnostic methods based on new technologies. The current age of biotechnology continues to challenge lawmakers as innovation unfolds faster than the current existing protective legislature. But no legal issue is more prominent in the biotechnological industry than ownership rights to these new developments.

Read More